레플리젠 (RGEN) 주가 전망: 목표주가, 배당, 최신 뉴스

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System.

It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits.

In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems.

The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands.

The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Repligen Corporation은 생명과학 분야 기업으로 북미, 유럽, 아시아태평양 및 그 외 시장에서 생물공정 기술과 시스템을 개발·상용화합니다.

제품군에는 hollow fiber consumables, KRM chromatography system, resins for new modalities과 같은 핵심 소모품 및 수지뿐만 아니라 실시간 공정 모니터링·제어 장비인 PATsmart MAVERICK 및 PATsmart MAVEN, 앳라인 세포배양 배지 분석기 PATsmart REBEL, 고해상도 샘플 분리장치 PATsmart ZipChip, PATsmart SoloVPE slope spectroscopy system 및 SoloVPE PLUS System 등이 포함됩니다. 또한 Protein A ligands(Protein A 친화 크로마토그래피 수지의 결합 성분)와 세포배양 성장인자 제품도 제공합니다.

크로마토그래피 제품으로는 OPUS pre-packed chromatography columns와 ELISA 검사 키트가 있으며, 여과 제품으로는 상류 퍼퓨전 및 세포배양 공정용 XCell ATF Cell Retention Systems, 하류 농축·버퍼교환·제형 공정용 TangenX flat sheet cassettes, KrosFlo tangential flow filtration 및 tangential flow depth filtration 시스템, ProConnex TFDF flow paths 등이 있습니다. 이밖에 slope spectroscopy 시스템 등 공정 분석 제품도 제공하며, OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, AVIPure 및 FlowVPX 등 다양한 브랜드로 제품을 판매합니다.

주요 고객은 생명과학·바이오의약품·진단 기업, 연구실 연구자 및 위탁생산(CMO) 업체이며, Navigo Proteins GmbH와 다수의 affinity ligand 개발을 위한 협력 계약을 체결하고 있습니다. 회사는 1981년에 설립되었고 본사는 Waltham, Massachusetts에 있습니다.

• 주소: Building 1, Suite 100 41 Seyon Street, Waltham, MA 02453, United States

• 전화번호: 781 250 0111

• 웹사이트: https://www.repligen.com

• 섹터: Healthcare

• 산업: Medical Instruments & Supplies

• 직원 수: 2,000